88 related articles for article (PubMed ID: 3876888)
1. Immunopotentiation in infectious disease, I. Effect of bestatin on the immune response.
Ormrod DJ; Cawley S; Miller TE
Chemioterapia; 1985 Aug; 4(4):313-23. PubMed ID: 3876888
[TBL] [Abstract][Full Text] [Related]
2. Studies on the mechanisms of action of the immunomodulator Bestatin in various screening test systems.
Schorlemmer HU; Bosslet K; Dickneite G; Lüben G; Sedlacek HH
Behring Inst Mitt; 1984 May; (74):157-73. PubMed ID: 6383322
[TBL] [Abstract][Full Text] [Related]
3. Partial review of immunotherapeutic pharmacology in stem cell transplantation.
Bierman PJ; Abe F; Buyukberber S; Ino K; Talmadge JE
In Vivo; 2000; 14(1):221-36. PubMed ID: 10757081
[TBL] [Abstract][Full Text] [Related]
4. Acceleration of age-associated immune decline and mortality by early repeated administration of bestatin to C57BL/6 mice.
Bruley-Rosset M; Payelle B; Rappaport H
J Biol Response Mod; 1986 Apr; 5(2):176-90. PubMed ID: 3488372
[TBL] [Abstract][Full Text] [Related]
5. Restoration of impaired immune functions of aged animals by chronic bestatin treatment.
Bruley-Rosset M; Florentin I; Kiger N; Schulz J; Mathé G
Immunology; 1979 Sep; 38(1):75-83. PubMed ID: 159863
[TBL] [Abstract][Full Text] [Related]
6. Immunopotentiation in infectious disease, II. Effect of bestatin on experimental infection.
Ormrod DJ; Clarke IA; Miller TE
Chemioterapia; 1985 Aug; 4(4):324-8. PubMed ID: 3902258
[TBL] [Abstract][Full Text] [Related]
7. The effects of bestatin on humoral response to sheep erythrocytes in non-treated and cyclophosphamide-immunocompromised mice.
Lis M; Szczypka M; Suszko A; Obmińska-Mrukowicz B
Immunopharmacol Immunotoxicol; 2013 Feb; 35(1):133-8. PubMed ID: 22957713
[TBL] [Abstract][Full Text] [Related]
8. Experimental immunological screening tests on pidotimod.
Coppi G; Manzardo S
Arzneimittelforschung; 1994 Dec; 44(12A):1411-6. PubMed ID: 7857333
[TBL] [Abstract][Full Text] [Related]
9. Ability of the immunomodulating dipeptide bestatin to activate cytotoxic mononuclear phagocytes.
Schorlemmer HU; Bosslet K; Sedlacek HH
Cancer Res; 1983 Sep; 43(9):4148-53. PubMed ID: 6871856
[TBL] [Abstract][Full Text] [Related]
10. [Phase I study of Bestatin: (I) A clinical study on determination of an optimal dose of Bestatin].
Saito K; Miyasato H; Tajima K; Ikeda S
Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt):211-7. PubMed ID: 6881973
[TBL] [Abstract][Full Text] [Related]
11. [A new antitumor drug with immunomodulating activity, ubenimex (bestatin)].
Tsukagoshi S
Gan To Kagaku Ryoho; 1987 Jul; 14(7):2385-91. PubMed ID: 3496857
[TBL] [Abstract][Full Text] [Related]
12. [Low molecular weight immunomodulators produced by microorganisms].
Ishizuka M
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2709-14. PubMed ID: 6508323
[TBL] [Abstract][Full Text] [Related]
13. Recent studies on antibiotics and small molecular immunomodulators with potential usefulness in treating lung cancer: Part II - Small molecular weight immunomodulators produced by microorganisms.
Umezawa H
Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):19-23. PubMed ID: 7056602
[TBL] [Abstract][Full Text] [Related]
14. Influence of Bestatin, a new immunomodulator, on various functions of human monocytes.
Jarstrand C; Blomgren H
J Clin Lab Immunol; 1982 Dec; 9(3):193-8. PubMed ID: 7166751
[TBL] [Abstract][Full Text] [Related]
15. Effect of fractional cyclophosphamide dosage on sheep red blood cell-delayed-type hypersensitivity response in mice.
Rondinone SN; Giovanniello OA; Barrios HA; Nota NR
J Immunol; 1983 Apr; 130(4):1600-3. PubMed ID: 6220061
[TBL] [Abstract][Full Text] [Related]
16. Do tuftsin and bestatin constitute a biopharmacological immunoregulatory system?
Mathé G
Cancer Detect Prev Suppl; 1987; 1():445-55. PubMed ID: 3319151
[TBL] [Abstract][Full Text] [Related]
17. Short- and long-term effects of T-cell modulating agents in experimental autoimmunity.
Mellergård J; Havarinasab S; Hultman P
Toxicology; 2004 Mar; 196(3):197-209. PubMed ID: 15036746
[TBL] [Abstract][Full Text] [Related]
18. Chronic bacterial infection models for BRM screening.
Dickneite G; Schorlemmer HU; Sedlacek HH
Behring Inst Mitt; 1984 May; (74):174-82. PubMed ID: 6383323
[TBL] [Abstract][Full Text] [Related]
19. Immune response against large tumors eradicated by treatment with cyclophosphamide and IL-12.
Tsung K; Meko JB; Tsung YL; Peplinski GR; Norton JA
J Immunol; 1998 Feb; 160(3):1369-77. PubMed ID: 9570556
[TBL] [Abstract][Full Text] [Related]
20. Effect of bestatin on mouse immune system and experimental murine tumors.
Ishizuka M; Masuda T; Kanbayashi N; Fukasawa S; Takeuchi T; Aoyagi T; Umezawa H
J Antibiot (Tokyo); 1980 Jun; 33(6):642-52. PubMed ID: 7419475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
